These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1839307)

  • 1. Erythromycin dosing error in bacterial endocarditis.
    J Am Dent Assoc; 1991 Nov; 122(11):10, 12. PubMed ID: 1839307
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Letter to the editor by Dr. Steven M. Pollack and author's response from Drs. Thomas J. Pallasch and Jorgen Slots. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the American Heart Association.
    Dajani AS; Taubert KA
    J Periodontol; 1992 May; 63(5):488. PubMed ID: 1527694
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocarditis prophylaxis.
    Dajani AS
    J Am Dent Assoc; 1988 Feb; 116(2):154. PubMed ID: 3257765
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacokinetics and tolerance of oral erythromycin stearate compared with erythromycin ethylsuccinate: implications for preventing endocarditis.
    Shanson DC; Tidbury P; McNabb WR; Tadayon M
    J Antimicrob Chemother; 1984 Aug; 14(2):157-63. PubMed ID: 6334070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment: bacterial endocarditis recommendations.
    Jones M
    Ann Pharmacother; 1992 May; 26(5):716. PubMed ID: 1591439
    [No Abstract]   [Full Text] [Related]  

  • 6. Medication for endocarditis prevention.
    Goldstein J
    J Am Dent Assoc; 1989 Feb; 118(2):144. PubMed ID: 2783940
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of bacterial endocarditis.
    JAMA; 1991 Apr; 265(13):1686-8. PubMed ID: 2002568
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitral valve prolapse: a review of the syndrome with emphasis on current antibiotic prophylaxis.
    Sandor GK; Vasilakos SS; Vasilakos JS
    J Can Dent Assoc; 1991 Apr; 57(4):321-5. PubMed ID: 1828388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses.
    Yakatan GJ; Rasmussen CE; Feis PJ; Wallen S
    J Clin Pharmacol; 1985; 25(1):36-42. PubMed ID: 3871797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypothermia associated with erythromycin].
    Cárdenes M; Artiles J; Arkuch A; Suárez S
    Med Clin (Barc); 1992 May; 98(18):715-6. PubMed ID: 1602886
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic prophylaxis for infective endocarditis. FDI Commission Working Group.
    Int Dent J; 1994 Jun; 44(3):215-22. PubMed ID: 7960160
    [No Abstract]   [Full Text] [Related]  

  • 12. High dose oral erythromycin for preventing endocarditis.
    Shanson DC; McNabb WR; Ruby K
    Lancet; 1983 Feb; 1(8319):299-300. PubMed ID: 6130318
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state].
    Potthast H; Schug B; Elze M; Schwerdtle R; Blume H
    Pharmazie; 1995 Jan; 50(1):56-60. PubMed ID: 7886126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More on endocarditis guidelines.
    Kopp WK
    N Y State Dent J; 1990 Mar; 56(3):8. PubMed ID: 2314774
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of pertussis treatment with erythromycin ethylsuccinate and stearate according to age.
    Kawai H; Aoyama T; Goto A; Iwai H; Murase Y
    Kansenshogaku Zasshi; 1994 Nov; 68(11):1324-9. PubMed ID: 7829900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholestasis and liver cell damage due to hypersensitivity to erythromycin stearate--recurrence following therapy with erythromycin succinate.
    Horn S; Aglas F; Horina JH
    Wien Klin Wochenschr; 1999 Jan; 111(2):76-7. PubMed ID: 10081126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin in acute pharyngitis: a comparison of efficacy and patient tolerance of two twice-daily preparations.
    Guthrie R
    Clin Ther; 1988; 10(5):530-5. PubMed ID: 2856596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Heart Association updates recommendations for prevention of infective endocarditis.
    Williams PM; Epstein JB
    J Can Dent Assoc; 1991 Jun; 57(6):494-5. PubMed ID: 1830511
    [No Abstract]   [Full Text] [Related]  

  • 19. Relative bioavailability of enteric coated pellets, stearate and ethylsuccinate formulations of erythromycin.
    Tjandramaga TB; Van Hecken A; Mullie A; Verbesselt R; De Schepper PJ; Verbist L; Josefsson K
    Pharmacology; 1984; 29(6):305-11. PubMed ID: 6334320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate.
    Ginsburg CM; McCracken GH; Steinberg JB; Crow SD; Dildy BF; Lancaster K; Olsen K
    Pediatr Infect Dis; 1982; 1(6):384-7. PubMed ID: 6761656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.